2026 is the year the federal government finally moved on kratom alkaloids, and the timing is what makes it confusing: two actions have already happened, a third is pending, and each one changes a different part of the category. This post is the breakdown — what exactly was scheduled, what the pending rule would do, and what all of it means for a 7-OH buyer. The state-level reactions (Florida, Virginia, Tennessee, Kansas, North Dakota, Massachusetts) are covered in the state map; this post is the federal side. Standing caveats: general information, not legal advice; regulatory status can change between publication and your read.
Action one: the August 26, 2026 scheduling
Effective August 26, 2026, the DEA placed three kratom-related compounds on temporary Schedule I:
- Mitragynine pseudoindoxyl (MP) — a semi-synthetic kratom alkaloid that has circulated in research-chemical and some supplement-adjacent products.
- MGM-15 — a kratom alkaloid analog that appeared in the market as a 7-OH substitute after 7-OH restrictions began appearing.
- MGM-16 — the second analog in the same substitute line.
What this does and does not mean for a 7-OH buyer:
- 7-hydroxymitragynine itself was NOT in this action. A legitimate 7-OH product is not made of these compounds, and the scheduling does not reach it directly.
- The lab panel matters now. These compounds were substitutes, and the substitute market was messy. A current batch COA for a 7-OH product’should show the related-compound screens are clean — that is one of the checks in our COA guide. If a vendor cannot produce a COA that screens for the scheduled analogs, that is a flag.
- Temporary Schedule I has a duration. Temporary scheduling is a faster-track federal mechanism with a set window before formal review — the compounds are controlled now, with the final status to be determined through the rulemaking process. The practical effect for buyers is immediate: these compounds are controlled, period.
Action two: the pending 7-OH threshold rule
The second federal action is the one that concerns the tablet category directly, and it is pending, not in effect:
- What it would do. The proposed action would regulate 7-hydroxymitragynine products that exceed a potency threshold — in plain terms, concentrated 7-OH products above a specified concentration level would change their federal status.
- Where it stands as of September 2026. The notice of intent was published July 6, 2026; the rule has not taken effect. It is the single most important open item in the category — if it lands, it changes the answer in every state at once, permitted or restricted.
- Why the threshold design. A threshold rule targets the concentrated product — the tablet category — while leaving lower-concentration material in its current position. That design is why the state actions on 7-OH products (rather than kratom leaf) and the federal threshold rule point in the same direction: the regulators are targeting the concentration, not the plant. The federal status guide keeps the current position tracked.
What the state wave tells you about the direction
The states did not wait for the federal rule. Florida restricted 7-OH products in June 2026; Virginia, Tennessee, Kansas, and North Dakota followed in July — before the August 26 scheduling took effect. The sequencing is the signal: state regulators moved first, on the pending federal notice, and the federal action on related alkaloids confirmed the direction weeks later. The pattern implies two things: first, states may keep acting before the federal threshold rule is final, and second, a state that has not acted yet is not necessarily a state that will not. The full sequence and the state-level detail are in the state map and the legal status guide.
What this means for buyers, practically
- Verify the batch, not just the brand. The scheduled analogs make the related-compound screens on your COA a real check, not a formality. Match the batch number to the report — batch verification is the step-by-step.
- Watch the threshold rule. If the pending rule takes effect, the category picture changes everywhere at once. The federal status guide is the standing reference, updated as the process moves.
- Keep your documentation. In a category where the federal status is actively changing, your order records and batch COAs are your documentation of what you received and when. That documentation is why the 9-point checklist ranks batch verification as a first-tier criterion.
- Know your state before anything else. The federal actions compound the state map, they do not replace it — the state map is still step one, and restricted-state positions are hard no-regardless of the federal status.
The responsible-use rules do not change with the legal landscape — spacing, real breaks, no mixing with depressants, 21+ only — the responsible use guide is the standing version. The FAQ center carries the short answers, and the shop serves permitted addresses with 21+ verification and batch COAs on every pack.